IRVINE, Calif., Feb. 20 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it will release fourth quarter and year-end 2006 financial results on March 6, 2007 before the U.S. markets open. ISTA will host a conference call with a simultaneous webcast to discuss these results at 10:30 a.m. Eastern Time on March 6.
To access the live conference call, U.S. and Canadian participants may dial 866-831-6267; international participants may dial 617-213-8857. The access code for the live call is 14699297. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 91253819. This conference call will also be webcast live and archived on ISTA’s website until April 6, 2007 at http://www.istavision.com.
ABOUT ISTA
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA’s products and product candidates addressing the $3.2 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, dry eye, vitreous hemorrhage, and diabetic retinopathy. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company’s product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals’ website at http://www.istavision.com.
ISTA Pharmaceuticals, Inc.
CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals; or Media: Jason Farber, jfarber@burnsmc.com, or KristinFaucette, kfaucette@burnsmc.com, or Investors: Juliane Snowden-Andrew,jsnowden-andrew@burnsmc.com, or Nicki Kahner, nkahner@burnsmc.com, all ofBurns McClellan, +1-212-213-0006
Web site: http://www.istavision.com/
